FY26 Appendix 4E
Filed with ASX · · 2 pages · English
Summary by 6ix AI
The report indicates a loss from ordinary activities after tax attributable to the owners of the company, along with no dividends declared during the financial period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/fy26-appendix-4e-8
Lumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- Lumos Receives FebriDx Order from PHASE Scientific
- FebriDx Commercial Traction Across Priority US Accounts
- FebriDx U.S. Rollout and Reimbursement Update - Amended
- FebriDx U.S. Rollout and Reimbursement Update
- FebriDx Paediatric Study Enrolment Milestone Achieved
Later from Lumos Diagnostics
- FY26 Full Year Results Announcement
- FebriDx Commercial Traction Continues Across US Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics